|[October 09, 2013]
Research and Markets: PharmaPoint: Alzheimer's Disease - Germany Drug Forecast and Market Analysis to 2022
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/xmlx9p/pharmapoint)
has announced the addition of the "PharmaPoint:
Alzheimer's Disease - Germany Drug Forecast and Market Analysis to 2022"
report to their offering.
PharmaPoint: Alzheimer's Disease - Germany Drug Forecast and Market
Analysis to 2022. There are no long-term effective therapies for
Alzheimer's Disease (AD), so this remains at the top of the list for
unmet needs. While physicians agree that symptomatic therapies are
relatively safe and effective, these therapies are still lacking because
of they cannot maintain their effects and lack mechanisms that alter the
course of the disease.
Passive immunotherapies will not capture a large percentage of the
market share, but will show successful sales statistics, given their
expected high prices. We believe that crenezumab will have the greatest
success in the Germn market in patients with established Alzheimer's
due to its dual-activity profile and preferential dosing scheme in
comparison with other drugs in this class.
- Overview of Alzheimer's Disease, including epidemiology, etiology,
symptoms, diagnosis, pathology and treatment guidelines as well as an
overview on the competitive landscape.
- Detailed information on the key drugs in Germany including product
description, safety and efficacy profiles as well as a SWOT analysis.
- Sales forecast for the top drugs in Germany from 2012-2022.
- Analysis of the impact of key events as well the drivers and
restraints affecting Germany Alzheimer's Disease market.
Reasons to buy
- Understand and capitalize by identifying products that are most likely
to ensure a robust return
- Stay ahead of the competition by understanding the changing
competitive landscape for Alzheimer's Disease
- Effectively plan your M&A and partnership strategies by identifying
drugs with the most promising sales potential
- Make more informed business decisions from insightful and in-depth
analysis of drug performance
- Obtain sales forecast for drugs from 2012-2022 in Germany
Key Topics Covered:
1.1 List of Tables
1.2 List of Figures
3 Disease Overview
4 Disease Management
5 Competitive Assessment
6 Opportunity and Unmet Need
7 Pipeline Assessment
8 Market Outlook
For more information visit http://www.researchandmarkets.com/research/xmlx9p/pharmapoint
About Research and Markets
Research and Markets is the world's leading source for international
market research reports and market data. We provide you with the latest
data on international and regional markets, key industries, the top
companies, new products and the latest trends.
[ Back To Technology News's Homepage ]